(2023) The novel treatments based on tissue engineering, cell therapy and nanotechnology for cutaneous leishmaniasis. International Journal of Pharmaceutics. p. 18. ISSN 0378-5173

(2022) Human interaction targets of SARS-COV-2 spike protein: A systematic review. European Journal of Inflammation.

(2021) Leishmanial apolipoprotein A-I expression: A possible strategy used by the parasite to evade the host's immune response. Future Microbiology. pp. 607-613.

(2021) Potential therapeutic targets shared between leishmaniasis and cancer. Parasitology. pp. 655-671.